IMMIX BIOPHARMA, INC. (IMMX) Net income 2021–2026
IMMIX BIOPHARMA, INC. (IMMX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$29.4MFY2026 · since FY2021: -$1.1M → -$29.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$29.4M | -36.0% |
| FY2025 | -$21.6M | -40.1% |
| FY2024 | -$15.4M | -87.4% |
| FY2023 | -$8.2M | +66.2% |
| FY2022 | -$24.4M | -2024.3% |
| FY2021 | -$1.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More IMMX financial trends
IMMX RevenueIMMX Net marginIMMX Gross profitIMMX Gross marginIMMX Operating incomeIMMX Operating marginIMMX Operating cash flowIMMX Free cash flowIMMX Capital expendituresIMMX Return on equityIMMX Stock buybacksIMMX Dividends paidIMMX Total assetsIMMX Total liabilitiesIMMX Shareholders’ equityIMMX overview →